Society of Nuclear Medicine
The Society of Nuclear Medicine in
Reston, Va., has begun a $5 million, five-year molecular imaging project called
“Bench to Bedside.” The project’s goal is to bring scientific
breakthroughs from the laboratory into clinical practice. The targeted technology
uses imaging to examine diseases at the molecular level. GE Healthcare, Bristol-Myers
Squibb Medical Imaging, Siemens Medical Solutions USA, Philips and FluoroPharma
contributed to the project.
LATEST NEWS